Colorado univ hlth SCI CTR - [10709 | X0C] lab test.autoimmune biomarker assays on serum samples the prostate, lung, colorectal, and ovarian (plco) cancer screening trial and alpha-tocopherol,…
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201500401P
- Awardee
-
The Regents Of The University Of Colorado UEI MW8JHK6ZYEX8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $120,854
Award facts
- Opportunity
-
- N02CP5269461 Solicitation number
- Autoimmune Biomarkers, Occupational Exposures and non-Hodgkin Lymphoma (NHL). Award Notice · Posted Aug 26, 2015
- Contract value 100% obligated
- $120,854.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $120,854 |
About this award
This is a $120,854 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Colorado-Denver. The contract is for the University of Colorado-Denver to provide laboratory testing and autoimmune biomarker assays on serum samples from participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Screening Trial. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public research university that frequently receives federal research funding through contracts and grants to support its medical, scientific, and other research activities.
Description
Colorado univ hlth SCI CTR - [10709 | X0C] lab test.autoimmune biomarker assays on serum samples the prostate, lung, colorectal, and ovarian (plco) cancer screening trial and alpha-tocopherol, beta-carotene (atbc) cancer sreening trial.
Quick answers
Who was awarded contract HHSN261201500401P?
HHSN261201500401P was awarded to The Regents Of The University Of Colorado by National Cancer Institute (National Institutes of Health) on September 23, 2015.
How much is contract HHSN261201500401P worth?
The government has obligated $120,854 on HHSN261201500401P.
Was contract HHSN261201500401P competed?
The extent of competition for HHSN261201500401P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award